Home › Compare › THOXF vs EQR

THOXF vs EQR: Dividend Comparison 2026

THOXF yields 1342.28% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 THOXF wins by $256529641.02M in total portfolio value
10 years
THOXF
THOXF
● Live price
1342.28%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$256529641.06M
Annual income
$223,739,932,781,849.56
Full THOXF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — THOXF vs EQR

📍 THOXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTHOXFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, THOXF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
THOXF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THOXF
Annual income on $10K today (after 15% tax)
$114,093.96/yr
After 10yr DRIP, annual income (after tax)
$190,178,942,864,572.12/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, THOXF beats the other by $190,178,942,861,325.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THOXF + EQR for your $10,000?

THOXF: 50%EQR: 50%
100% EQR50/50100% THOXF
Portfolio after 10yr
$128264820.55M
Annual income
$111,869,966,392,834.58/yr
Blended yield
87.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

THOXF
No analyst data
Altman Z
1.2
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THOXF buys
0
EQR buys
0
No recent congressional trades found for THOXF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTHOXFEQR
Forward yield1342.28% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$256529641.06M ✓$40.5K
Annual income after 10y$223,739,932,781,849.56 ✓$3,819.61
Total dividends collected$254114577.79M ✓$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: THOXF vs EQR ($10,000, DRIP)

YearTHOXF PortfolioTHOXF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$144,928$134,228.19$11,248$547.57+$133.7K → THOXF
2$1,973,152$1,818,079.26$12,701$666.53+$1.96M → THOXF
3$25,244,531$23,133,258.23$14,405$814.59+$25.23M → THOXF
4$303,616,445$276,604,796.20$16,413$999.84+$303.60M → THOXF
5$3,433,963,985$3,109,094,388.86$18,795$1,232.92+$3433.95M → THOXF
6$36,538,353,033$32,864,011,569.61$21,639$1,527.95+$36538.33M → THOXF
7$365,902,043,313$326,806,005,567.23$25,057$1,903.80+$365902.02M → THOXF
8$3,450,111,200,144$3,058,596,013,799.80$29,197$2,385.87+$3450111.17M → THOXF
9$30,644,587,175,375$26,952,968,191,220.19$34,250$3,008.70+$30644587.14M → THOXF
10$256,529,641,059,501$223,739,932,781,849.56$40,467$3,819.61+$256529641.02M → THOXF

THOXF vs EQR: Complete Analysis 2026

THOXF — Stock

BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. It sells its products through own sales team, distributors, and OEM partnerships. The company was founded in 2000 and is headquartered in Hellerup, Denmark.

Full THOXF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this THOXF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THOXF vs SCHDTHOXF vs JEPITHOXF vs OTHOXF vs KOTHOXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.